Patent US5681852A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5681852A Expired / Lapsed US ⏱️ 0.0 years remaining

Desquamation compositions

Assignee: TEXTILE RESEARCH INSTITUTE Inc
•
Filing: 1995-06-07
•
Granted: 1997-10-28
•
Expires: 2015-06-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The subject invention relates to desquamation compositions comprising a combination of sulfhydryl compounds and zwitterionic surfactants. The subject invention further relates to methods of desquamation in mammalian skin and treating acne in mammalian skin.

Inventors

  • 👤 Donald L. Bissett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 10:03
CPC Classifications
A; A61; A61Q; A61Q19/00; A61K; A61K31/00; A61K31/60; A61K8/00; A61K8/18; A61K8/30; A61K8/33; A61K8/34; A61K8/342; A61K8/37; A61K8/40; A61K8/44; A61K8/442; A61K8/447; A61K8/46; A61K8/55; A61K8/553; A61K8/60; A61K8/64; A61K8/72; A61K8/73; A61K8/731; A61K8/735; A61K8/738; A61K8/81; A61K8/8105; A61K8/8111; A61K8/84; A61K8/86; A61Q19/08; A61Q5/00; A61Q5/006

Claims Analysis

Total Claims: 29
Claim 1
Independent Claim 178 words
A topical composition for desquamation in mammalian skin, comprising: a) desquamation actives comprising: (i) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR14## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof: and (ii) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically-and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 2
Dependent Claim 178 words
A topical composition for desquamation in mammalian skin, comprising: a) desquamation actives comprising: (i) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR14## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof: and (ii) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically-and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 3
Dependent Claim 30 words
The composition of claim 1 wherein the sulfhydryl compound is selected from the group consisting of N-acetyl-L-cysteine, glutathione, cosmetically-and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof.
Claim 4
Dependent Claim 18 words
The composition of claim 2 wherein the composition further comprises from about 0.1% to about 10% salicylic acid.
Claim 5
Dependent Claim 51 words
The composition of claim 2 wherein: (a) R 2 and R 3 are selected from the group consisting of CH 3 , CH 2 CH 2 OH and CH 2 CH 2 CH 2 OH; (b) X is CO 2 or SO 3 ; and (c) m is 2 or 3.
Claim 6
Dependent Claim 40 words
The composition of claim 4 wherein R 4 has from 1 to about 3 carbon atoms when X is CO 2 , and R 4 has from about 2 to about 4 carbon atoms when X is SO 3 .
Claim 7
Dependent Claim 12 words
The composition of claim 5 wherein the zwitterionic surfactant is behenyl betaine.
Claim 8
Dependent Claim 55 words
The composition of claim 5 wherein: a) R 1 has from about 11 to about 18 carbon atoms; b) R 2 and R 3 are CH 3 ; and c) R 4 has 1 carbon atom when X is CO 2 ; and R 4 has 3 carbon atoms when X is SO 3 .
Claim 9
Dependent Claim 28 words
The composition of claim 7 wherein: (a) R 4 has 3 carbon atoms; (b) X is SO 3 ; (c) m is 3; and (d) n is 1.
Claim 10
Dependent Claim 22 words
The composition of claim 7 wherein the sulfhydryl compound is N-acetyl-L-cysteine, a cosmetically- and/or pharmaceutically-acceptable salt of N-acetyl-L-cysteine, or a combination thereof.
Claim 11
Dependent Claim 17 words
The composition of claim 9 wherein the zwitterionic surfactant is cocoamidopropyl betaine or cetyl propyl hydroxy sultaine.
Claim 12
Dependent Claim 12 words
The composition of claim 9 wherein the zwitterionic surfactant is cetyl betaine.
Claim 13
Dependent Claim 12 words
The composition of claim 9 wherein the zwitterionic surfactant is stearyl betaine.
Claim 14
Dependent Claim 28 words
The composition of claim 7 wherein: (a) R 4 has 1 carbon atom; (b) X is CO 2 ; (c) m is 3; and (d) n is 1.
Claim 15
Dependent Claim 20 words
The topical composition of claim 1 wherein said desquamation actives consist essentially of said zwitterionic surfactant and said sulfhydryl compound.
Claim 16
Dependent Claim 171 words
A topical composition comprising: (a) from about 0.1% to about 10% of a zwitterionic surfactant having the structure: ##STR15## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof; (b) from about 0.1% to about 20% of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 17
Dependent Claim 171 words
A topical composition comprising: (a) from about 0.1% to about 10% of a zwitterionic surfactant having the structure: ##STR15## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof; (b) from about 0.1% to about 20% of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 18
Dependent Claim 28 words
The topical composition of claim 15 comprising from about 0.5% to about 5% of said sulfhydryl compound and from about 0.5% to about 2% of said zwitterionic surfactant.
Claim 19
Independent Claim 187 words
A method of achieving desquamation of mammalian skin comprising topically applying to a mammal in need of such treatment a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR16## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of, CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 20
Independent Claim 187 words
A method of achieving desquamation of mammalian skin comprising topically applying to a mammal in need of such treatment a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR16## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of, CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 21
Dependent Claim 77 words
The method of claim 17 wherein: (a) R 2 and R 3 are selected from the group consisting of CH 3 , CH 2 CH 2 OH and CH 2 CH 2 CH 2 OH; (b) X is CO 2 or SO 3 ; (c) m is 2 or 3; and (d) the sulfhydryl compound is selected from the group consisting of N-acetyl-L-cysteine, glutathione, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof.
Claim 22
Dependent Claim 47 words
The method of claim 18 wherein: (a) the amount of sulfhydryl compound applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin; and (b) the amount of zwitterionic surfactant applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin.
Claim 23
Dependent Claim 47 words
The method of claim 19 wherein: (a) the amount of sulfhydryl compound applied is from about 0.02 mg/cm 2 skin to about 0.06 mg/cm 2 skin; and (b) the amount of zwitterionic surfactant applied is from about 0.02 mg/cm 2 skin to about 0.06 mg/cm 2 skin.
Claim 24
Dependent Claim 31 words
The method of claim 20 wherein; (a) the zwitterionic surfactant is stearyl betaine; and (b) the sulfhydryl compound is N-acetyl-L-cysteine, a cosmetically- and/or pharmaceutically-acceptable salt of N-acetyl-L-cysteine, or a combination thereof.
Claim 25
Dependent Claim 31 words
The method of claim 20 wherein; (a) the zwitterionic surfactant is cetyl betaine; and (b) the sulfhydryl compound is N-acetyl-L-cysteine, a cosmetically- and/or pharmaceutically-acceptable salt of N-acetyl-L-cysteine, or a combination thereof.
Claim 26
Independent Claim 189 words
A method of treating acne in mammalian skin comprising topically applying to a mammal susceptible to or suffering from ache a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR17## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 27
Independent Claim 189 words
A method of treating acne in mammalian skin comprising topically applying to a mammal susceptible to or suffering from ache a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR17## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 28
Dependent Claim 77 words
The method of claim 23 wherein: (a) R 2 and R 3 are selected from the group consisting of CH 3 , CH 2 CH 2 OH and CH 2 CH 2 CH 2 OH; (b) X is CO 2 or SO 3 ; (c) m is 2 or 3; and (d) the sulfhydryl compound is selected from the group consisting of N-acetyl-L-cysteine, glutathione, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof.
Claim 29
Dependent Claim 47 words
The method of claim 24 wherein: (a) the amount of sulfhydryl compound applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin; and (b) the amount of zwitterionic surfactant applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-10-27 2001-04-28 2001-10-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-10-27 2005-04-28 2005-10-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-10-27 2009-04-28 2009-10-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag